245 related articles for article (PubMed ID: 17544971)
1. Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
Charatcharoenwitthaya P; Lindor KD
Clin Liver Dis; 2007 Feb; 11(1):37-54, viii. PubMed ID: 17544971
[TBL] [Abstract][Full Text] [Related]
2. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
[TBL] [Abstract][Full Text] [Related]
3. [Non-alcoholic steatohepatitis: natural history and diagnosis].
Larrey D
Gastroenterol Clin Biol; 2003; 27(8-9):793-8. PubMed ID: 14586250
[No Abstract] [Full Text] [Related]
4. Diagnosis and therapy of nonalcoholic steatohepatitis.
Torres DM; Harrison SA
Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
[TBL] [Abstract][Full Text] [Related]
5. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
Ali R; Cusi K
Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
7. [Non-alcoholic steatohepatitis].
Petit P; Zarski JP
Gastroenterol Clin Biol; 2000 Feb; 24(2):157-9. PubMed ID: 12687955
[No Abstract] [Full Text] [Related]
8. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
Cowin GJ; Jonsson JR; Bauer JD; Ash S; Ali A; Osland EJ; Purdie DM; Clouston AD; Powell EE; Galloway GJ
J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619
[TBL] [Abstract][Full Text] [Related]
9. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
[TBL] [Abstract][Full Text] [Related]
10. Methods for assessing intrahepatic fat content and steatosis.
Fabbrini E; Conte C; Magkos F
Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):474-81. PubMed ID: 19550313
[TBL] [Abstract][Full Text] [Related]
11. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
Pagadala M; Zein CO; McCullough AJ
Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
Schwenzer NF; Springer F; Schraml C; Stefan N; Machann J; Schick F
J Hepatol; 2009 Sep; 51(3):433-45. PubMed ID: 19604596
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin' s disease with fulminant non-alcoholic steatohepatitis.
Kosmidou IS; Aggarwal A; Ross JJ; Worthington MG
Dig Liver Dis; 2004 Oct; 36(10):691-3. PubMed ID: 15506670
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of magnetic resonance tomography in liver diseases].
Rödl W
Fortschr Med; 1985 Jun; 103(24):649-53. PubMed ID: 3894182
[No Abstract] [Full Text] [Related]
15. Non-alcoholic steatohepatitis in children.
Roberts EA
Clin Liver Dis; 2007 Feb; 11(1):155-72, x. PubMed ID: 17544977
[TBL] [Abstract][Full Text] [Related]
16. [Unusual radiologic aspect of a hydatid cyst].
Tomasini P; Guillot D; Sylla B; Belliol E; Salamand P; Sabbah PM; Briant JF
Med Trop (Mars); 1993; 53(2):209-12. PubMed ID: 8412591
[TBL] [Abstract][Full Text] [Related]
17. [A man with non alcoholic steatohepatitis].
Tran A; Anty R
Gastroenterol Clin Biol; 2003; 27(8-9):806-8. PubMed ID: 14586252
[No Abstract] [Full Text] [Related]
18. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
[No Abstract] [Full Text] [Related]
20. [Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis].
Van Beers B
Bull Mem Acad R Med Belg; 2009; 164(1-2):44-50; discussion 51-2. PubMed ID: 19718953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
